Inventor
KENT STEPHEN B H
US38 patents
⚠️ This page may combine multiple inventors who share the name “KENT STEPHEN B H”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCRIPPS RESEARCH INST
9 patentsUS6184344B1Feb 6, 2001
Synthesis of proteins by native chemical ligation
SCRIPPS RESEARCH INST202 citations98
US5891993AApr 6, 1999
Template assembled synthetic protein
SCRIPPS RESEARCH INST20 citations92
US6307018B1Oct 23, 2001
General chemical ligation
SCRIPPS RESEARCH INST30 citations91
US6476190B1Nov 5, 2002
Process for preparing modified proteins
SCRIPPS RESEARCH INST17 citations90
US5854389ADec 29, 1998
Process for preparing modified proteins
SCRIPPS RESEARCH INST18 citations90
US6228654B1May 8, 2001
Methods for structure analysis of oligosaccharides
SCRIPPS RESEARCH INST31 citations89
US6495314B1Dec 17, 2002
Process for characterizing proteins
SCRIPPS RESEARCH INST19 citations83
US7408026B1Aug 5, 2008
Synthesis of proteins by native chemical ligation
SCRIPPS RESEARCH INST4 citations62
US6642357B1Nov 4, 2003
Process for preparing modified proteins
SCRIPPS RESEARCH INST2 citations60
NEW YORK BLOOD CENTER INC
6 patentsUS5204096AApr 20, 1993
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
NEW YORK BLOOD CENTER INC53 citations96
US5565548AOct 15, 1996
Pre-S gene coded peptide hepatitis B immunogens and synthetic lipid vesicle carriers
NEW YORK BLOOD CENTER INC41 citations92
US5158769AOct 27, 1992
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
NEW YORK BLOOD CENTER INC30 citations92
US4861588AAug 29, 1989
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers
NEW YORK BLOOD CENTER INC34 citations92
US4847080AJul 11, 1989
Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipide vesicle carriers
NEW YORK BLOOD CENTER INC34 citations92
US4803156AFeb 7, 1989
Peptide-beta-lactamase conjugates for enzyme-linked immunoassays
NEW YORK BLOOD CENTER INC14 citations73
UNIV ROCKEFELLER
4 patentsUS5792664AAug 11, 1998
Methods for producing and analyzing biopolymer ladders
UNIV ROCKEFELLER99 citations98
US6750061B2Jun 15, 2004
Method and product for the sequence determination of peptides using a mass spectrometer
UNIV ROCKEFELLER26 citations92
US6271037B1Aug 7, 2001
Method and product for the sequence determination of peptides using a mass spectrometer
UNIV ROCKEFELLER29 citations92
US7341874B2Mar 11, 2008
Method for detecting post-translation modifications of peptides
UNIV ROCKEFELLER0 citations52
APPLIED BIOSYSTEMS
4 patentsUS5186898AFeb 16, 1993
Automated polypeptide synthesis apparatus
APPLIED BIOSYSTEMS61 citations96
US4816513AMar 28, 1989
Automated polypeptide synthesis process
APPLIED BIOSYSTEMS88 citations96
US4668476AMay 26, 1987
Automated polypeptide synthesis apparatus
APPLIED BIOSYSTEMS123 citations96
US5273715ADec 28, 1993
Automated system for providing a sequence of chemicals to a reaction process
APPLIED BIOSYSTEMS31 citations90
AMYLIN PHARMACEUTICALS INC
3 patentsUS7118737B2Oct 10, 2006
Polymer-modified synthetic proteins
AMYLIN PHARMACEUTICALS INC60 citations91
US7482425B2Jan 27, 2009
Compositions for lipid matrix-assisted chemical ligation
AMYLIN PHARMACEUTICALS INC5 citations60
US8034900B2Oct 11, 2011
Water-soluble thioester and selenoester compounds and methods for making and using the same
AMYLIN PHARMACEUTICALS INC0 citations31
GRYPHON THERAPEUTICS
3 patentsUS6977292B2Dec 20, 2005
Nucleophile-stable thioester generating compounds, methods of production and use
GRYPHON THERAPEUTICS8 citations70
US7094871B2Aug 22, 2006
Solid phase native chemical ligation of unprotected or N-terminal cysteine protected peptides in aqueous solution
GRYPHON THERAPEUTICS2 citations59
US7030218B2Apr 18, 2006
Pseudo native chemical ligation
GRYPHON THERAPEUTICS1 citations47